BIOMAT Database Logo BIOMAT Database Logo

Significance of mesangial IgM deposition in "minimal change" nephrotic syndrome. 1982

A R Vilches, and D R Turner, and J S Cameron, and C S Ogg, and C Chantler, and D G Williams

During a 6-year period, 64 patients with a nephrotic syndrome, shown histologically to result from minimal change nephropathy, were studied for a mean of 4.5 years. Fifty of the patients showed no glomerular immunoglobulin on immunofluorescent or immunoperoxidase study, but 14 had mesangial deposits of IgM. The onset characteristics, response to treatment, and long-term course were similar in the two groups. We conclude that IgM deposition in the mesangium in patients with minimal change nephrotic syndrome is of no prognostic value, and our data do not suggest that this group of patients, although a histopathologic entity, represent a clinically distinct group.

UI MeSH Term Description Entries
D007075 Immunoglobulin M A class of immunoglobulin bearing mu chains (IMMUNOGLOBULIN MU-CHAINS). IgM can fix COMPLEMENT. The name comes from its high molecular weight and originally was called a macroglobulin. Gamma Globulin, 19S,IgM,IgM Antibody,IgM1,IgM2,19S Gamma Globulin,Antibody, IgM
D007223 Infant A child between 1 and 23 months of age. Infants
D007678 Kidney Glomerulus A cluster of convoluted capillaries beginning at each nephric tubule in the kidney and held together by connective tissue. Glomerulus, Kidney
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009404 Nephrotic Syndrome A condition characterized by severe PROTEINURIA, greater than 3.5 g/day in an average adult. The substantial loss of protein in the urine results in complications such as HYPOPROTEINEMIA; generalized EDEMA; HYPERTENSION; and HYPERLIPIDEMIAS. Diseases associated with nephrotic syndrome generally cause chronic kidney dysfunction. Childhood Idiopathic Nephrotic Syndrome,Frequently Relapsing Nephrotic Syndrome,Multi-Drug Resistant Nephrotic Syndrome,Pediatric Idiopathic Nephrotic Syndrome,Steroid-Dependent Nephrotic Syndrome,Steroid-Resistant Nephrotic Syndrome,Steroid-Sensitive Nephrotic Syndrome,Multi Drug Resistant Nephrotic Syndrome,Nephrotic Syndrome, Steroid-Dependent,Nephrotic Syndrome, Steroid-Resistant,Nephrotic Syndrome, Steroid-Sensitive,Nephrotic Syndromes,Steroid Dependent Nephrotic Syndrome,Steroid Resistant Nephrotic Syndrome,Steroid Sensitive Nephrotic Syndrome,Steroid-Dependent Nephrotic Syndromes,Steroid-Resistant Nephrotic Syndromes,Steroid-Sensitive Nephrotic Syndromes,Syndrome, Nephrotic,Syndrome, Steroid-Sensitive Nephrotic
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D005260 Female Females

Related Publications

A R Vilches, and D R Turner, and J S Cameron, and C S Ogg, and C Chantler, and D G Williams
[Clinical significance of IgM deposition in the mesangium and mesangial hypercellularity in adult minimal change nephrotic syndrome].
January 2006, Nihon Jinzo Gakkai shi,
A R Vilches, and D R Turner, and J S Cameron, and C S Ogg, and C Chantler, and D G Williams
The clinical significance of mesangial IgM deposits and mesangial hypercellularity in minimal change nephrotic syndrome.
January 1984, American journal of kidney diseases : the official journal of the National Kidney Foundation,
A R Vilches, and D R Turner, and J S Cameron, and C S Ogg, and C Chantler, and D G Williams
[Incidental mesangial IgA deposition in minimal change nephrotic syndrome(MCNS)].
October 2003, Nihon Jinzo Gakkai shi,
A R Vilches, and D R Turner, and J S Cameron, and C S Ogg, and C Chantler, and D G Williams
Significance of mesangial IgA deposition in minimal change nephrotic syndrome: a study of 60 cases.
September 1990, Yonsei medical journal,
A R Vilches, and D R Turner, and J S Cameron, and C S Ogg, and C Chantler, and D G Williams
[Histologic transition in patients with minimal-change nephrotic syndrome to mesangial IgM nephropathy].
December 1986, Revista clinica espanola,
A R Vilches, and D R Turner, and J S Cameron, and C S Ogg, and C Chantler, and D G Williams
[Clinico-pathological evaluation of mesangial IgA deposition of minimal change with nephrotic syndrome].
October 1990, Nihon Jinzo Gakkai shi,
A R Vilches, and D R Turner, and J S Cameron, and C S Ogg, and C Chantler, and D G Williams
Mesangial IgA deposition in minimal change nephrotic syndrome: coincidence of different entities or variant of minimal change disease?
March 2006, Clinical nephrology,
A R Vilches, and D R Turner, and J S Cameron, and C S Ogg, and C Chantler, and D G Williams
Clinical significance of IgM mesangial deposits in the nephrotic syndrome.
January 1985, Nephron,
A R Vilches, and D R Turner, and J S Cameron, and C S Ogg, and C Chantler, and D G Williams
Mesangial alterations in steroid-responsive minimal change nephrotic syndrome.
January 1982, Virchows Archiv. A, Pathological anatomy and histology,
A R Vilches, and D R Turner, and J S Cameron, and C S Ogg, and C Chantler, and D G Williams
Electron microscopic study of the cases of minimal change nephrotic syndrome with mesangial IgA deposition.
December 1992, Yonsei medical journal,
Copied contents to your clipboard!